Skip to content

Why Is Clover Wellness (CLOV) Stock Up Today? Supervisor Chelsea Clinton acquired 100,000 shares of CLOV stock 

Right now, shareholders of Clover Health (NASDAQ: CLOV) are grinning ear to ear. Although clov stock chart remains down more than 25% year-to-date (YTD), shares of the firm are up over 20% today.

Why specifically is Clover Health and wellness trading greater right now?

Over the weekend break, it was reported that Clover supervisor Chelsea Clinton had actually lately purchased shares of CLOV stock. The deal, which took place on March 3, saw Clinton purchase 100,000 shares for an average cost of $2.52 per share. In total, Clinton’s current transaction totaled up to $252,530, according to a Type 4 submitted to the united state Stocks as well as Exchange Payment (SEC).

Why Is CLOV Stock Up Today?
Right now, CLOV stock is up in action to Clinton’s purchase, which investors are viewing as a favorable signal. Many times, director trading activity like this is necessary to track because experts often have a better view of a business’s lasting development potential than retail financiers.

So, with that in mind, are various other experts of Clover bullish on the firm? In the past 12 months, experts have actually bought 2.2 million shares as well as offered 22.9 million shares. That’s a web of 20.6 million shares offered. This mass insider selling appears to associate with CLOV stock’s decrease of greater than 60% over the past one year.

Still, with Clinton’s recent purchase, financiers are wondering who else is wagering large on Clover Health and wellness. Let’s jump right in.

That Else Is Betting Big on Clover Health?
As of the fourth quarter, 160 institutional investors very own shares of CLOV stock. That marks a quarter-0ver-quarter (QOQ) rise of 8.8%. Throughout the period, the complete quantity of shares held by institutional financiers additionally increased from 105.7 million to 129.8 million, up nearly 23% QOQ. Let’s have a look at the top 5 institutional investors.

Vanguard has 25.9 million shares or 7.65% ownership. The company acquired 8.8 million shares throughout Q4.
Greenoaks Capital Partners possesses 24.8 million shares or 7.34% ownership. The firm offered 24.8 million shares throughout Q4.
Baillie Gifford has 7.8 million shares or 2.3% ownership. The firm purchased 2.6 million shares during Q4.
2 Sigma Investments has 6.6 million shares or 1.95% ownership. The firm purchased all 6.6 million shares throughout Q4.
PNC Financial Services (NYSE: PNC) has 6.4 million shares or 1.88% ownership. The firm sold 249,850 shares throughout Q4.
Out of the leading 5 investors, three funds minimized their placements as well as two funds enhanced their placements. Greenoaks Capital Allies had the most notable deal, as the fund marketed concerning 50% of its existing position throughout Q4. Two Sigma’s 6.6 million share purchase was also remarkable, as the acquisition placed it among the top five investors.